apiLogger::2021-11-15 05:03:44,718::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-15 05:03:44,779::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-15 05:03:44,779::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp18ap_7v5 
apiLogger::2021-11-15 05:03:44,782::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-15 05:03:44,782::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-15 05:03:45,717::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-15 05:03:45,717::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp18ap_7v5
apiLogger::2021-11-15 05:03:49,012::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-15 05:03:49,012::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-15 05:03:49,012::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-15 05:03:49,012::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-15 05:03:49,017::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-11-15 05:03:49,017::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-15 05:03:49,017::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-11-15 05:03:49,017::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-11-15 05:03:49,017::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubjectâ€™s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-11-15 05:03:49,017::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-11-15 05:03:49,017::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-11-15 05:03:49,017::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-11-15 05:03:49,017::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-11-15 05:03:49,017::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-11-15 05:04:12,371::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-11-15 05:04:12,371::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
